Cme Group Inc (CME) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CME Annual Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Cme Group Inc's cash generation and deployment strategy.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
3 Months
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income1,154.30
Depreciation & amortization27.20
Amortization of Other Assets56.10
Private Equity0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Sale of Assets0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation21.80
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions0.00
Gains (Losses) on Extinguishment of Debt0.00
Derivative Gain Loss On Derivative Net-
Impairment Of Goodwill And Intangible Assets-
Impairment Of Investments-
Deconsolidation Gain Or Loss Amount-
Income taxes314.20
Gain (Loss) on Investments22.90
Increase (Decrease) in Accounts Receivable-295.80
Increase (Decrease) in Accounts Payable3.60
Increase (Decrease) in Other Accrued Liabilities20.90
Accrued liabilities0.00
Increase (Decrease) in Prepaid Expense and Other Assets-50.10
Other Working Capital-4.10
Other Noncash Income (Expense)-11.10
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities1,259.90
Investing Activities
Capital Expenditures-21.80
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities1.10
Payments to Acquire Available-for-sale Securities, Debt-0.80
Payments for (Proceeds from) Derivative Instrument, Investing Activities0.00
Proceeds From Sale Of Other Assets-
Proceeds Repayments Of Long Term Investment-
Proceeds From Exercise Right Priveleges-
Proceeds From Divestiture Of Business Net-
Payment For Acquisition Of Subsidiarys Interests From The Non Controlling Interest-
Securit. Available-for-Sale Acq.0.00
Sale of longterm investment0.00
Sales of Loans0.00
Payments to Acquire Other Investments-1.50
Purchases of assets0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Interest in Joint Venture0.00
Proceeds from Divestiture of Businesses and Interests in Affiliates0.00
Investment in Affiliates0.00
Net change in federal funds0.00
Other Net0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-23.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-538.70
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock0.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Change in Deposits0.00
Other Net0.00
Other net-164,105.90
Net Change In Securities Lending Program Liability-
Common Stock Issued To Partner Exchange-
Minority Interest Decrease From Redemptions-
Contingent Consideration Settlement-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents164,079.50
Change In Performance Bond And Guaranty Fund Contributions5,379.20
Net change in federal funds0.00
Dividends paid-2,697.60
Net Cash Flow from Financing Activities2,116.50
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow1,238.10
Total Cash Flow3,353.40
4 historic quarters locked

Sign in to unlock the full Cme Group Inc cash flow history.

About Cme Group Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 24, 2026
  • Source: cme-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001156375-26-000047

Figures are derived from filed reports and may be restated. Historical data is subject to revision.